Management of hereditary cancers

Cancer is not hereditary. However, there are predisposition genes which, if mutated, expose members of the same family to a high risk. These cancers with a hereditary component account for 5% of all cancers and can be treated by the oncogenetics team.

The IUCT Oncopole offers oncogenetic consultations for breast, ovarian and colorectal cancers*. They are intended for patients who developed cancer at an early age and/or who have a family history of cancer, and for cancer-free persons with a family history of cancer. You can request an appointment on your own initiative or be referred by a physician.



A physician specialized in oncogenetics examines the patient's family tree to determine if the family meets the criteria for being considered high-risk. If this is the case, the patient is offered a genetic assessment.


Genetic analysis

Molecular analyses are performed on a blood sample   to determine whether the person is or is not carrier of a mutation on a gene involved in one of the three diseases.
Depending on the results, a personalized monitoring program may be initiated.


* Purpan IUCT has a dermatology, endocrinology and nephrology oncogenetics service.